The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Jul 2016 08:33

BROKER RATINGS SUMMARY: Bernstein Cuts Next And M&S To Underperform

Read more
12 Jul 2016 16:16

DIRECTOR DEALINGS SUMMARY: Chairman-Connected Firm Buys EKF Shares

Read more
12 Jul 2016 11:32

DIRECTOR DEALINGS: Chairman-Connected Firm Buys EKF Diagnostics Shares

Read more
6 Jul 2016 10:44

Panmure maintains 'buy' on EKF Diagnostics

(ShareCast News) - EKF Diagnostics shares rose on Wednesday as Panmure Gordon reiterated a 'buy' rating and target price of 14p after an upbeat trading update. In a first half trading update, EKF said sales and adjusted EBITDA are ahead of market expectations for the six months ended 30 June 2016.

Read more
6 Jul 2016 08:06

EKF Diagnostics Anticipates Earnings Ahead Of Market Expectations

Read more
10 Jun 2016 14:11

Directors dealings: NAIT boosts stake in EKF Diagnostics to 14.1%

(ShareCast News) - Harwood Capital, acting as investment manager on behalf of North Atlantic Smaller Companies Investment Trust PLC, picked up another large batch of shares in EKF Diagnostics. Christoper Mills, who was named to the post of non-executive chairman at the global point-of-care medical d

Read more
2 Jun 2016 15:07

UPDATE: EKF Diagnostics Says Earnings Ahead; Raises GBP4.8 Million (ALLISS)

Read more
2 Jun 2016 08:20

EKF Diagnostics Earnings Ahead Of Budget; Launches Bookbuild (ALLISS)

Read more
26 May 2016 15:08

UK Shareholder Meetings Calendar - Next 7 Days

Read more
11 May 2016 08:37

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

Read more
26 Apr 2016 09:43

EKF Diagnostics To Repay Loan From Zwanzinger Family (ALLISS)

Read more
15 Apr 2016 15:06

EKF Diagnostics To Redeem GBP3 Million Convertible Loan (ALLISS)

Read more
12 Apr 2016 07:53

EKF Diagnostics Sees Positive Start To 2016 After "Difficult" 2015

Read more
11 Apr 2016 12:20

EKF Diagnostics non-exec resigns as new chairman joins

(ShareCast News) - Ron Zwanziger has resigned as non-executive director of EKF Diagnostics with immediate effect. The AIM-listed point-of-care business confirmed the news in a statement on Monday. Last week, EKF appointed Christopher Mills as non-executive chairman with immediate effect. Mills is c

Read more
11 Apr 2016 08:57

EKF Diagnostics Ex-Chairman Gives Up Board Role As Mills Takes Charge

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.